| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 28.756 | 42.448 | 38.123 | 28.798 | 26.089 | 20.779 | 19.946 | 22.723 | 39.881 |
| Total Income - EUR | - | 28.756 | 42.448 | 38.123 | 28.798 | 39.004 | 20.779 | 19.946 | 27.110 | 53.410 |
| Total Expenses - EUR | - | 24.079 | 40.083 | 24.779 | 18.183 | 17.574 | 16.343 | 9.848 | 25.638 | 52.795 |
| Gross Profit/Loss - EUR | - | 4.677 | 2.365 | 13.344 | 10.616 | 21.431 | 4.436 | 10.098 | 1.472 | 615 |
| Net Profit/Loss - EUR | - | 3.815 | 1.686 | 12.963 | 10.082 | 21.036 | 4.384 | 9.637 | 1.246 | 525 |
| Employees | - | 0 | 2 | 1 | 1 | 2 | 1 | 1 | 3 | 2 |
Check the financial reports for the company - Tincovicidym Curier S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 52.109 | 51.152 | 50.162 | 70.979 | 76.924 | 37.621 | 79.683 | 71.341 |
| Current Assets | - | 4.203 | 2.897 | 1.168 | -237 | 1.829 | 345 | 3.204 | 3.869 | 2.675 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 0 | 0 | 0 | 133 | 0 | -13 |
| Cash | - | 4.203 | 2.897 | 1.168 | -237 | 1.829 | 345 | 3.071 | 3.869 | 2.688 |
| Shareholders Funds | - | 3.859 | 5.480 | 18.342 | 28.069 | 48.573 | 51.880 | 36.330 | 12.196 | 12.653 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 344 | 49.526 | 33.979 | 21.856 | 24.236 | 25.390 | 4.495 | 71.355 | 61.363 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5320 - 5320" | |||||||||
| CAEN Financial Year |
5320
|
|||||||||
Comments - Tincovicidym Curier S.r.l.